Wells Fargo & Company Vyant Bio, Inc. Transaction History

Wells Fargo & Company

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.52 - $0.89 $17 - $29	-33 Reduced 18.44%	146 $0
Q2 2022 Aug 12, 2022	BUY	$0.62 - $1.37 $10 - $23	17 Added 10.49%	179 $0
Q3 2021 Nov 15, 2021	SELL	$2.26 - $3.74 $63 - $104	-28 Reduced 14.74%	162 $0
Q2 2021 Aug 16, 2021	BUY	$2.88 - $4.81 $334 - $557	116 Added 156.76%	190 $1,000
Q1 2021 May 13, 2021	BUY	$2.89 - $8.6 $213 - $636	74 New	74 $0

213K

Ticker VYNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,343,200
Description
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule c...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.